B. Riley Wealth Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

B. Riley Wealth Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,717	Closed	-$221K	–	583
2015 Q2	$221K	Sell	3,717 -57	-2%	-$3.33K	0.05%	424
2015 Q1	$217K	Buy	3,774 +141	+4%	+$7.71K	0.05%	442
2014 Q4	$183	Buy	+3,633	New	+$177K	﹤0.01%	1420
2014 Q3	–	Sell	-3,330	Closed	-$150K	–	1242
2014 Q2	$150K	Buy	+3,330	New	+$143K	0.04%	559
2013 Q4	–	Sell	-4,530	Closed	-$161K	–	697
2013 Q3	$161K	Buy	4,530 +120	+3%	+$4.22K	0.06%	403
2013 Q2	$146K	Buy	+4,410	New	+$147K	0.05%	441

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

BWM

Braver Wealth Management Needham, Massachusetts $616M AUM 12.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

B. Riley Wealth Advisors's IHE Position: Q3 2015 in Review

B. Riley Wealth Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2015, closing a stake of 3,717 shares — an estimated $221K sold.

B. Riley Wealth Advisors first reported a position in IHE in Q2 2013 and held it in 6 quarters. The position peaked at $221K in Q2 2015. 102 funds tracked by Wall St. Rank hold IHE as of Q3 2015.

B. Riley Wealth Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
B. Riley Wealth Advisors sold 3,717 iShares US Pharmaceuticals ETF shares in Q3 2015, an estimated $221K.
B. Riley Wealth Advisors first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 6 quarters.
B. Riley Wealth Advisors's iShares US Pharmaceuticals ETF position peaked at $221K in Q2 2015.
102 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.